Literature DB >> 6958367

Aziridinylbenzoquinone (AZQ) treatment of central nervous system leukemia.

B A Kamen, J S Holcenberg, S E Siegel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6958367

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  3 in total

1.  Phase II evaluation of diaziquone (CI-904, AZQ) in the treatment of human malignant glioma.

Authors:  J Maral; M Poisson; B F Pertuiset; P Mashaly; M Weil; C Jacquillat; A J Grillo-Lopez
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

2.  A phase I/II study of 24 hour intravenous AZQ in recurrent primary brain tumors.

Authors:  M C Chamberlain; M D Prados; P Silver; V A Levin
Journal:  J Neurooncol       Date:  1988-12       Impact factor: 4.130

Review 3.  Neoplastic meningitis.

Authors:  L Kim; M J Glantz
Journal:  Curr Treat Options Oncol       Date:  2001-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.